ULTRAFILTRATED FRACTION OF KOREAN RED GINSENG EXTRACT IMPROVES MEMORY IMPAIRMENT OF TG2576 MICE VIA INHIBITION OF SOLUBLE AÎ’ PRODUCTION AND ACETYLCHOLINESTERASE ACTIVITY
Keywords:
Ginseng, Nil, Acetylcholinesterase, Ultrafiltration, MemoryAbstract
Objective: The goal of this study was to research for an effective fraction on memory improvement of Korean red ginseng.
Methods: In this study, 80 % ethanol red ginseng extract (RE) was divided into inner fluid (REUI) and outer fluid (REUO) by the ultrafiltration and then REUO was further separated into four fractions namely, REUO-00, REUO-30, REUO-50 and REUO-70, respectively, by Diaion HP-20 column chromatography.
Results: REUO has protected more significantly the H2O2-induced SHSY-5Y cell death than REUI. Interestingly, the hydrophobic parts of the REUO (REUO-EtOHs) such as REUO-30,-50 and-70 decreased more significantly the H2O2-induced cell death than its hydrophilic part (REUO-00) in a dose-dependent manner. Then, we focused on the activity of a candidate for cholinergic functions, because memory deficits of neurodegenerative diseases are closely associated with cholinergic dysfunctions. The REUO-EtOHs (1.25 mg/ml) inhibited the activity of the acetylcholinesterase and its half maximal inhibitory concentration (IC50) was about 2.358 mg/ml. Additionally, we investigated whether the intake of the REUO (50 mg/kg/d) during 12 w could improve memory impairment of 12-month old Tg2576 mice and decrease total soluble amyloid-β (Aβ) proteins in the mouse brain cortex. The REUO alleviated significantly the memory impairment and successfully reduced the levels of the soluble Aβ proteins in the mouse cortex.
Conclusion: We finally suggest that the REUO, including majorly its hydrophobic part that may be considered as more effective for memory improvement, will be highly considered as valuable candidate for the memory-enhancing ingredients against cholinergic dysfunctions and cognitive impairments of neurodegenerative diseases including Alzheimer's disease.
Keywords: Ginseng, Alzheimer's disease, Acetylcholinesterase, Ultrafiltration, MemoryÂ
Downloads
References
Suh YH, Checler F. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev 2002;54:469-525.
Ballard C, Gauthier S, Corebett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Lancet 2011;377:1019-31.
Bartus RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgetten a generation following the cholinergic hypothesis. Exp Neurol 2000;163:495-529.
Ohta H, Arai S, Akita K, Ohta T, Fukuda S. Effects of NK-4 in a transgenic mouse model of Alzheimer’s disease. PLoS One 2012;7:e30007.
Hanaa HA, Hoda FB, Wagdy KBK, Hassan MEA, Samir MO. The possible therapeutic role of Jasonia candicans and Jasonia montana extracts in the regression of Alzheimer’s disease in an experimental model. Am J Biochem Biotechnol 2013;9:144-61.
Jin SH, Jung NP. Studies on the physiological and biochemical effect of Korean ginseng. Korean J Ginseng Sci 1996;20:431–71.
Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004;27:429–35.
Mook Jung I, Hong HS, Boo JH, Lee KH, Yun SH, Cheong MY, et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. J Neurosci Res 2001;63:509-15.
In JG, Kim EJ, Lee BS, Park MH, Yang DC. Saponin analysis and red ginseng production using the simplified method of Korean ginseng (Panax ginseng C. A. Meyer). Korean J Plant Res 2006;19:133–8.
Ellman GL, Lourtney DK, Andres V, Feathertone RM. A new and rapid colorimetric determination of acetylcholinesterase. Biochem Pharmacol 1961;7:88-95.
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
Shen Z, Wang G, Lin SZ. Two-way shuttle box avoidance conditioning and brain NADH in rats. Physiol Behav 1990;48:515-7.
Lahiri DK, Farlow MR, Greig NH, Sambamurti K. Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 2002;56:267-81.
Seol SY, Kim BR, Hong SC, Yoo JH, Lee KH, Lee HJ, et al. The effective preparation of protopanaxadiol saponin-enriched fraction from ginseng using the ultrafiltration. Nat Prod Sci 2014;20:58-64.
Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 1995;16:661-74.
Shin KY, Lee JY, Won BY, Jung HY, Chang KA, Koppula S, et al. YH. BT-11 is effective for enhancing cognitive function in the elderly humans. Neurosci Lett 2009;465:157-9.
Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH. The amyloid beta-protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem 1997;69:1177–84.
Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. Amyloid beta-peptide inhibites high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 1998;70:2179-87.
Bartus RT, Dean III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-14.
Snape MF, Misra A, Murray TK, Souza RJD, Williams JL, Cross AJ. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacol 1999;38:181-93.
Park CH, Kim SH, Choi W, Lee YJ, Kang SS, Kim JS, et al. Novel anticholinesterase and antiamnesic activities of dehydroevodiaminezHCl, a constituent of Evodia rutaecarpa. Planta Med 1996;62:405–9.
Giacobini E. From molecular structure to Alzheimer therapy. Jpn J Pharmacol 1997;74:225–41.
Lau FC, Shukitt-Hale B, Joseph JA. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging 2005;26:128–32.
Behl C, Davis JB, Lesley R. Hydrogen peroxide mediates amyloid protein activity. Cell 1994;77:817–27.